Skip to Main Content

Advertisement

Skip Nav Destination

Abstract PD2-12: Palbociclib in combination with fulvestrant or tamoxifen as treatment for hormone receptor positive (HR+) metastatic breast cancer (MBC) with prior chemotherapy for advanced disease (TBCRC 035) A phase II study with pharmacodynamics markers

Cancer Res (2019) 79 (4_Supplement): PD2-12.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Johannes Ettl
  • Seock-Ah Im
  • Jungsil Ro
  • Norikazu Masuda
  • Marco Colleoni
  • Patrick Schnell
  • Eustratios Bananis
  • Dongrui R. Lu
  • Massimo Cristofanilli
  • Hope S. Rugo
  • Richard S. Finn
Breast Cancer Research (2020) 22 (1)
Close Modal

or Create an Account

Close Modal
Close Modal